121 related articles for article (PubMed ID: 28111136)
21. Glyoxalase 1 as a Therapeutic Target in Cancer and Cancer Stem Cells.
Kim JY; Jung JH; Lee SJ; Han SS; Hong SH
Mol Cells; 2022 Dec; 45(12):869-876. PubMed ID: 36172978
[TBL] [Abstract][Full Text] [Related]
22. Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity.
Gaens KH; Stehouwer CD; Schalkwijk CG
Curr Opin Lipidol; 2013 Feb; 24(1):4-11. PubMed ID: 23298958
[TBL] [Abstract][Full Text] [Related]
23. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background.
Kalousová M; Zima T; Tesar V; Dusilová-Sulková S; Skrha J
Mutat Res; 2005 Nov; 579(1-2):37-46. PubMed ID: 16084533
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis.
Chen S; Yin L; Xu Z; An FM; Liu AR; Wang Y; Yao WB; Gao XD
Neurosci Lett; 2016 Jan; 612():193-198. PubMed ID: 26679229
[TBL] [Abstract][Full Text] [Related]
25. Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE.
Matsui T; Oda E; Higashimoto Y; Yamagishi S
Cardiovasc Diabetol; 2015 Jan; 14():1. PubMed ID: 25582325
[TBL] [Abstract][Full Text] [Related]
26. Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells.
Kuhla B; Lüth HJ; Haferburg D; Weick M; Reichenbach A; Arendt T; Münch G
J Neurosci Res; 2006 Jun; 83(8):1591-600. PubMed ID: 16555297
[TBL] [Abstract][Full Text] [Related]
27. iRAGE as a novel carboxymethylated peptide that prevents advanced glycation end product-induced apoptosis and endoplasmic reticulum stress in vascular smooth muscle cells.
Maltais JS; Simard E; Froehlich U; Denault JB; Gendron L; Grandbois M
Pharmacol Res; 2016 Feb; 104():176-85. PubMed ID: 26707030
[TBL] [Abstract][Full Text] [Related]
28. Inhibition by active site directed covalent modification of human glyoxalase I.
Holewinski RJ; Creighton DJ
Bioorg Med Chem; 2014 Jul; 22(13):3301-8. PubMed ID: 24856185
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress and glyoxalase I activity mediate dicarbonyl toxicity in MCF-7 mamma carcinoma cells and a tamoxifen resistant derivative.
Nass N; Sel S; Ignatov A; Roessner A; Kalinski T
Biochim Biophys Acta; 2016 Jun; 1860(6):1272-80. PubMed ID: 26971627
[TBL] [Abstract][Full Text] [Related]
30. Role of receptor for advanced glycation end products (RAGE) and its ligands in cancer risk.
Yamagishi S; Matsui T; Fukami K
Rejuvenation Res; 2015 Feb; 18(1):48-56. PubMed ID: 25472493
[TBL] [Abstract][Full Text] [Related]
31. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
[TBL] [Abstract][Full Text] [Related]
32. The role of glyoxalase system in renal hypoxia.
Inagi R; Kumagai T; Fujita T; Nangaku M
Adv Exp Med Biol; 2010; 662():49-55. PubMed ID: 20204770
[TBL] [Abstract][Full Text] [Related]
33. Reactive oxygen species induce apoptosis in bronchial epithelial BEAS-2B cells by inhibiting the antiglycation glyoxalase I defence: involvement of superoxide anion, hydrogen peroxide and NF-κB.
Antognelli C; Gambelunghe A; Talesa VN; Muzi G
Apoptosis; 2014 Jan; 19(1):102-16. PubMed ID: 24002659
[TBL] [Abstract][Full Text] [Related]
34. Peroxynitrite-mediated glyoxalase I epigenetic inhibition drives apoptosis in airway epithelial cells exposed to crystalline silica via a novel mechanism involving argpyrimidine-modified Hsp70, JNK, and NF-κB.
Antognelli C; Gambelunghe A; Muzi G; Talesa VN
Free Radic Biol Med; 2015 Jul; 84():128-141. PubMed ID: 25841781
[TBL] [Abstract][Full Text] [Related]
35. Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats.
Wu F; Feng JZ; Qiu YH; Yu FB; Zhang JZ; Zhou W; Yu F; Wang GK; An LN; Ni FH; Wu H; Zhao XX; Qin YW; Luo HD
Atherosclerosis; 2013 Aug; 229(2):287-94. PubMed ID: 23880178
[TBL] [Abstract][Full Text] [Related]
36. Actein protects against methylglyoxal-induced oxidative damage in osteoblastic MC3T3-E1 cells.
Suh KS; Chon S; Choi EM
J Sci Food Agric; 2017 Jan; 97(1):207-214. PubMed ID: 26991449
[TBL] [Abstract][Full Text] [Related]
37. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
[TBL] [Abstract][Full Text] [Related]
38. Blockade of receptor for advanced glycation end products protects against systolic overload-induced heart failure after transverse aortic constriction in mice.
Liu Y; Yu M; Zhang Z; Yu Y; Chen Q; Zhang W; Zhao X
Eur J Pharmacol; 2016 Nov; 791():535-543. PubMed ID: 27393458
[TBL] [Abstract][Full Text] [Related]
39. Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.
Wetzels S; Wouters K; Schalkwijk CG; Vanmierlo T; Hendriks JJ
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212304
[TBL] [Abstract][Full Text] [Related]
40. Antiglycative Activity and RAGE Expression in Rett Syndrome.
Cordone V; Pecorelli A; Benedusi M; Santini S; Falone S; Hayek J; Amicarelli F; Valacchi G
Cells; 2019 Feb; 8(2):. PubMed ID: 30781346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
